| Marc D Erlitz, MD | |
|
12333 Ne 130th Ln, Suite 500, Kirkland, WA 98034 | |
| (425) 353-3788 | |
| (425) 353-8041 |
| Full Name | Marc D Erlitz |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 12333 Ne 130th Ln, Kirkland, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114028628 | NPI | - | NPPES |
| 0078551 | Other | WA | L&I |
| 1248103 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD00013191 (Washington) | Primary |
| Entity Name | Surgical Center Anesthesiologists, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861061731 PECOS PAC ID: 5890164248 Enrollment ID: O20221207002407 |
News Archive
The Burzynski Research Institute, Inc. (BRI) has announced that its antineoplaston A10 and antineoplaston AS2-1 therapy (ANP) has been granted orphan drug designation by the U.S. Food and Drug Administration ("FDA") for the treatment of gliomas. It is estimated that in 2008 more than 21,000 men and women in the U.S. will be diagnosed with this type of cancer, with prevalence estimated at approximately 84,000 cases.
IWatch news reports on this emerging issue while Modern Healthcare notes that a New Mexico Telehealth Project May Be National Modelrecent developments regarding health information technology.
Parent Project Muscular Dystrophy, the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne) and Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases, will collaborate on a benefit/risk study in Duchenne.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
A series of experiments at EPFL provide conclusive evidence that the brain uses a single mechanism (supramodality) to estimate confidence in different senses such as audition, touch, or vision. The study is published in the Journal of Neuroscience.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc D Erlitz, MD Po Box 94181, Everett, WA 98208 Ph: (425) 353-3788 | Marc D Erlitz, MD 12333 Ne 130th Ln, Suite 500, Kirkland, WA 98034 Ph: (425) 353-3788 |
News Archive
The Burzynski Research Institute, Inc. (BRI) has announced that its antineoplaston A10 and antineoplaston AS2-1 therapy (ANP) has been granted orphan drug designation by the U.S. Food and Drug Administration ("FDA") for the treatment of gliomas. It is estimated that in 2008 more than 21,000 men and women in the U.S. will be diagnosed with this type of cancer, with prevalence estimated at approximately 84,000 cases.
IWatch news reports on this emerging issue while Modern Healthcare notes that a New Mexico Telehealth Project May Be National Modelrecent developments regarding health information technology.
Parent Project Muscular Dystrophy, the leading advocacy organization working to end Duchenne muscular dystrophy (Duchenne) and Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focusing on the development and marketing of innovative pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases, will collaborate on a benefit/risk study in Duchenne.
For the first time, next-generation DNA sequencing technologies have been turned on typhoid fever - a disease that kills 600,000 people each year. The results will help to improve diagnosis, tracking of disease spread and could help to design new strategies for vaccination.
A series of experiments at EPFL provide conclusive evidence that the brain uses a single mechanism (supramodality) to estimate confidence in different senses such as audition, touch, or vision. The study is published in the Journal of Neuroscience.
› Verified 6 days ago
Dr. Holly Anne Nelson, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St # Ms 69, Kirkland, WA 98034 Phone: 206-540-0175 | |
Julian W Klos, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th Street, Kirkland, WA 98034 Phone: 425-899-1000 | |
June L. Lee, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1000 | |
Thomas R. Stibbins, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1000 | |
Teri L. Mcfall, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1000 | |
Jan E. Stroh, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1000 |